Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma.

@article{Liu2014Cytokeratin1T,
  title={Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma.},
  author={Zeming Liu and Xiaoyu Li and Lan Shi and Y. S. J. Maimaiti and Tianwen Chen and Zhi Li and Shuntao Wang and Yiquan Xiong and Hui Guo and Wenshan He and Chunping Liu and Xiu Nie and Wen Zeng and Tao Huang},
  journal={International journal of clinical and experimental medicine},
  year={2014},
  volume={7 8},
  pages={
          2304-8
        }
}
OBJECTIVE To assess usefulness of cytokeratin 19 (CK19), thyroperoxidase (TPO), Hector Battifora mesothelial epitope-1 (HBME-1) and galectin-3 (GAL3) in evaluation of aggressive behavior of PTCs. METHODS All available clinical and pathological data were reviewed in 168 papillary thyroid cancer patients; while the values as predictive markers of PTC were tested by univariate and multivariate analysis. RESULTS According to the univariate set of tests, positive expression of CK19 and negative… CONTINUE READING
Highly Cited
This paper has 21 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

A high - throughput proteomic approach provides distinct signatures for thyroid cancer behavior

  • T IsicDencic, D Cvejic, I Paunovic, S Tatic, M Havelka, S Savin
  • Clin Cancer Res
  • 2011